Blood Cancer OncTalk
GRACE
Experts Discuss Their Approach to Auto-Transplant for Young Standard-Risk Myeloma Patients
- 15 views
- March 20, 2024
GRACE
Oncologists' Guidance on Treating Smoldering Myeloma: Panel Discussion
- 118 views
- March 15, 2024
GRACE
Choosing CAR T-Cell or Bispecifics After Standard Myeloma Therapy Exhaustion: Panel Discussion
- 13 views
- March 11, 2024
GRACE
A Summary of Efficacy and Safety Data From Bispecific Antibodies in Myeloma
FEATURING
Sridevi Rajeeve
- 139 views
- March 6, 2024
- 1
GRACE
The Future of Bispecific Antibodies in Myeloma
FEATURING
Sridevi Rajeeve
- 20 views
- March 6, 2024
GRACE
Epcoritamab in NHL - Incidence and Management of CRS
FEATURING
Tycel Phillips
- 158 views
- February 16, 2024
- 1
GRACE
Efficacy of Epcoritamab and Glofitamab in R/R DLBCL
FEATURING
Tycel Phillips
- 27 views
- February 16, 2024
GRACE
Updates on Bispecific Antibodies in Myeloma
FEATURING
Sridevi Rajeeve
- 129 views
- February 15, 2024
- 2
GRACE
Overview on Current Immunotherapy Options in Myeloma
FEATURING
Sridevi Rajeeve
- 100 views
- February 15, 2024
- 1
GRACE
The Impact of Transplant on Survival in Myeloma and Lymphoma
FEATURING
Marco Ruiz
- 18 views
- February 15, 2024
GRACE
Current Utility of Autologous Bone Marrow Transplants in Myeloma and Lymphoma
FEATURING
Marco Ruiz
- 30 views
- February 15, 2024
GRACE
Overview and Logistics of Bone Marrow Transplant
FEATURING
Marco Ruiz
- 74 views
- February 15, 2024
GRACE
The TRIANGLE Study: Ibrutinib Maintenance for MCL
FEATURING
Tycel Phillips
- 214 views
- June 30, 2023
GRACE
CAR T-Cell vs. Bispecific Therapies for Blood Cancers: How Oncologists Determine Treatment
- 1,962 views
- June 30, 2023
- 5
GRACE
Tailoring Chemotherapy for Geriatric Patients With Advanced Stage Aggressive Lymphomas
FEATURING
Mazie Tsang
- 18 views
- June 30, 2023
GRACE
Multiple Myeloma & Cellular Therapies: A Patient-Centric Primer
FEATURING
Sridevi Rajeeve
- 63 views
- March 28, 2023
GRACE
Considerations for Older Adults With Aggressive Lymphoma
FEATURING
Mazie Tsang
- 72 views
- March 28, 2023
